Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended LH Administration (ELHA) to Increase Recruitable Antral Follicles
NCT06883890Phase 2Not yet recruiting
- Sponsor
- Azienda Ospedaliera Universitaria Policlinico
- Start
- Mar 2025
- Primary completion
- Nov 2025
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, open-label trial of lutropin alfa in female infertility (2 arms), sponsored by Azienda Ospedaliera Universitaria Policlinico. Primary endpoint: Serum Anti-Mullerian Hormone at 60 days. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
lutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT06883890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06883890.